Single Panel MDMA/Ecstasy

Product information

Single Panel Drug Urine Rapid Test detects 1 substance with specific result for the substance analyzed.  This urine drug test detects: MDMA (Ecstasy)500.

Advantages of Urine test

• Easy to collect
• No limit to sample volume
• Long detection window 

General information

The Single Panel MDMA Rapid Test, Ecstasy (Urine) is a rapid immunochromatographic test for the detection of Methylenedioxymethamphetamine (basic ingredient of Ecstasy) in human urine at the threshold concentration – limit of 500 ng/ml. This test also detects other compounds, please refer to the Analytical Specificity table in this package insert.

Methylenedioxymethamphetamine (Ecstasy) is a designer drug first synthesized in 1914 by a German pharmaceutical company for the treatment of obesity1. Those who take it frequently have experienced side effects, such as increased muscle tension and sweating. MDMA is clearly not a stimulant, although it has the ability to increase blood pressure and heart rhythm in common with amphetamine. MDMA produces some changes in perception by increasing sensitivity to light, difficulty concentrating and blurred vision in some subjects.

It is thought that its mechanism of action occurs through the neurotransmitter serotonin. MDMA can also release dopamine, although the general opinion is that this is a secondary effect of the drug (Nichols and Oberlender, 1990). The main effect of MDMA, which has probably occurred in anyone who has taken a reasonable dose, is to produce a contraction of the jaws.

The MDMA Rapid Test (Urine) indicates positive results when the concentration of Methylenedioxymethamphetamine in the urine exceeds 500 ng/mL.

Test procedure

Interpret results within minutes for simultaneous specimen collection and screening.

1. Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
2. Bring the pouch to room temperature before opening it. Remove the test panel from the sealed pouch and use it within one hour.
3. Remove the cap.
4. With the arrow pointing toward the urine specimen, immerse the test panel vertically in the urine specimen for at least 10 to 15 seconds. Immerse the dipstick to at least the level of the wavy lines, but not above the arrow on the test panel.
5. Replace the cap and place the test panel on a non-absorbent flat surface.
6. Start the timer and wait for the colored line(s) to appear.
7. The drug strip result should be read at 5 minutes. Do not interpret the result after 10 minutes.

Interpretation of the results

Negative result:* A colored line appears in the Control region (C) and colored lines appear in the Test region (T). This negative result means that the concentrations in the urine sample are below the designated cut-off levels for a particular drug tested.

*NOTE: The shade of the colored lines(s) in the Test region (T) may vary. The result should be considered negative whenever there is even a faint line.

Positive result: A colored line appears in the Control region (C) and NO line appears in the Test region (T). The positive result means that the drug concentration in the urine sample is greater than the designated cut-off for a specific drug.

Invalid result: No line appears in the Control region (C). Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for Control line failure. Read the directions again and repeat the test with a new test card. If the result is still invalid, contact us.